Integra LifeSciences (IART) Tops Q4 EPS by 3c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Above Consensus, FY19 Revenue Views Below Estimates

Go back to Integra LifeSciences (IART) Tops Q4 EPS by 3c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Above Consensus, FY19 Revenue Views Below Estimates
Integra LifeSciences Holdings (NASDAQ: IART) Delayed: 15.22 +0.12 (0.79%)
Previous Close $15.10    52 Week High $88.86 
Open $14.98    52 Week Low $54.75 
Day High $15.24    P/E N/A 
Day Low $14.88    EPS $-0.59 
Volume 2,169,062